NAFDAC DG says Nigeria to continue clinical trial of Hydroxychloroquine for the treatment of COVID19 patients despite WHO’s suspension
The Director-General of the National Agency for Food and Drug Administration NAFDAC, Professor Mojisola Adeyeye, says Nigeria will continue its ...
Read moreDetails